Porous nanofibrous PLLA scaffolds for vascular tissue engineering.

Tissue-engineered small-diameter vascular grafts are needed for patients requiring replacement of their injured coronary and below-the-knee vessels. Understanding the interactions between the scaffolds and implanted cells and therefore the phenotype control of smooth muscle cells (SMCs) is critical for constructing functional vascular grafts. In this study, the effect of nanofibrous (NF) poly-L-lactide (PLLA) scaffolds on phenotype control of human aortic smooth muscle cells (HASMCs) was investigated. A tubular NF PLLA scaffold for blood vessel regeneration was fabricated and cell seeding studies showed cell distribution throughout the scaffold. It was found that NF PLLA scaffolds preferentially supported contractile phenotype of HASMCs under the in vitro culture conditions, as evidenced by elevated gene expression level of SMCs contractile markers including smooth muscle myosin heavy chain, smoothelin and myocardin. In vivo subcutaneous implantation studies confirmed HASMCs differentiation in the implants. Taken together, the results showed promising application of the porous NF PLLA scaffolds for reconstruction of tissue-engineered vascular grafts.

[1]  Benjamin Chu,et al.  Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts , 2007, Proceedings of the National Academy of Sciences.

[2]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[3]  Peter X Ma,et al.  The effect of surface area on the degradation rate of nano-fibrous poly(L-lactic acid) foams. , 2006, Biomaterials.

[4]  M. Kotaki,et al.  Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. , 2004, Biomaterials.

[5]  H. T. Yang,et al.  Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. , 2003, American journal of physiology. Heart and circulatory physiology.

[6]  T. Nakaki,et al.  Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. , 1999, European journal of pharmacology.

[7]  G. Owens,et al.  Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. , 1989, The Journal of biological chemistry.

[8]  P. Ma,et al.  Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. , 2009, Biomaterials.

[9]  Robert M. Nerem,et al.  Dynamic Mechanical Conditioning of Collagen-Gel Blood Vessel Constructs Induces Remodeling In Vitro , 2000, Annals of Biomedical Engineering.

[10]  Anthony Atala,et al.  The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. , 2009, Biomaterials.

[11]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  T. Nakaki,et al.  Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. , 1999, European journal of pharmacology.

[13]  Alexander M Seifalian,et al.  Current status of prosthetic bypass grafts: a review. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  A. Bank,et al.  Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. , 1996, Circulation.

[15]  Peter X Ma,et al.  Macroporous and nanofibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres. , 2006, Journal of biomedical materials research. Part A.

[16]  M. Rabinovitch,et al.  Understanding and treating vein graft atherosclerosis. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[17]  Wei He,et al.  Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. , 2009, Journal of biomedical materials research. Part A.

[18]  Peter X Ma,et al.  Biomimetic materials for tissue engineering. , 2008, Advanced drug delivery reviews.

[19]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[20]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[21]  William V Giannobile,et al.  Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Peter X Ma,et al.  Induction of osteoblast differentiation phenotype on poly(L-lactic acid) nanofibrous matrix. , 2008, Biomaterials.

[23]  Jacqueline T Johanas,et al.  Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts. , 2009, Biomaterials.

[24]  R M Nerem,et al.  Vascular tissue engineering. , 2001, Annual review of biomedical engineering.

[25]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.